Overview Olmesartan Medoxomil in Diabetes Mellitus Status: Completed Trial end date: 2009-07-01 Target enrollment: Participant gender: Summary This is a study in diabetic patients with at least one additional cardiovascular risk factor and normoalbuminuria prior to randomization. Phase: Phase 3 Details Lead Sponsor: Sankyo Pharma GmbhTreatments: OlmesartanOlmesartan Medoxomil